Welcome to LookChem.com Sign In|Join Free
  • or
(S)-N-(1-(hydroxyamino)-1-oxo-3-phenylpropan-2-yl)benzamide is a complex organic compound with the molecular formula C16H16N2O3. It is a chiral molecule, with the "S" prefix indicating that it has the (S)-configuration, meaning the hydroxyamino group is positioned on the left side when looking at the molecule from the perspective of the carbonyl group. (S)-N-(1-(hydroxyamino)-1-oxo-3-phenylpropan-2-yl)benzamide is characterized by a benzamide group attached to a 3-phenylpropan-2-yl moiety, which features a hydroxyamino group and a carbonyl group. It is a white crystalline solid and is often used in pharmaceutical research as a precursor or intermediate in the synthesis of various drugs, particularly those targeting the central nervous system. Its specific applications and properties can vary widely depending on the context in which it is used.

23912-61-0

Post Buying Request

23912-61-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

23912-61-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 23912-61-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,9,1 and 2 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 23912-61:
(7*2)+(6*3)+(5*9)+(4*1)+(3*2)+(2*6)+(1*1)=100
100 % 10 = 0
So 23912-61-0 is a valid CAS Registry Number.

23912-61-0Downstream Products

23912-61-0Relevant academic research and scientific papers

Identification of 1,5,7-Triazabicyclododecene and Polystyrene-Supported Superbases as Efficient Hydroxylaminolysis Agents of Sterically Hindered and Epimerizable Esters

Pierre, Romain,Gaigne, Frédéric,El-Bazbouz, Ghizlane,Mouis, Grégoire,Ouvry, Gilles,Tomas, Loic,Harris, Craig S.

, p. 1102 - 1106 (2018)

In modern pharmaceutical research, the need for reliable protocols for the preparation of chemical libraries in a controlled manner is quintessential to driving the Design-Make-Test cycle in drug discovery programs. In this letter, we communicate the iden

In silico design of HDAC6 inhibitors with neuroprotective effects

Bello, Martiniano,de Pedro, Nuria,Correa-Basurto, José,Gómez-Vidal, José Antonio,Rosales-Hernández, Martha Cecilia,Sixto-López, Yudibeth

, (2021/11/24)

HDAC6 has emerged as a molecular target to treat neurodegenerative disorders, due to its participation in protein aggregate degradation, oxidative stress process, mitochondrial transport, and axonal transport. Thus, in this work we have designed a set of

A convenient procedure for the solid-phase synthesis of hydroxamic acids on PEGA resins

Nandurkar, Nitin S.,Petersen, Rico,Qvortrup, Katrine,Komnatnyy, Vitaly V.,Taveras, Kennedy M.,Le Quement, Sebastian T.,Frauenlob, Robin,Givskov, Michael,Nielsen, Thomas E.

supporting information; experimental part, p. 7121 - 7124 (2012/01/14)

An efficient method for the solid-phase synthesis of hydroxamic acids is described. The method comprises the nucleophilic displacement of esters immobilized on PEGA resins with hydroxylamine/sodium hydroxide in isopropanol. The hydroxyaminolysis protocol

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 23912-61-0